138 related articles for article (PubMed ID: 8890723)
21. Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves' lymphocytes cultured in vitro with phytohaemagglutinin (PHA).
Knox AJ; von Westarp C; Row VV; Volpé R
Metabolism; 1976 Nov; 25(11):1217-23. PubMed ID: 185485
[TBL] [Abstract][Full Text] [Related]
22. Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter.
Vitti P; Chiovato L; Tonacchera M; Bendinelli G; Mammoli C; Capaccioli A; Fiore E; Pretell E; Pinchera A
J Clin Endocrinol Metab; 1994 May; 78(5):1020-5. PubMed ID: 7909816
[TBL] [Abstract][Full Text] [Related]
23. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
[TBL] [Abstract][Full Text] [Related]
25. Graves' immunoglobulin G stimulates iodide efflux in FRTL-5 thyroid cells.
Shoda Y; Kondo Y; Kobayashi I
J Clin Endocrinol Metab; 1993 Jul; 77(1):94-7. PubMed ID: 8100833
[TBL] [Abstract][Full Text] [Related]
26. Cross talk between substance P and melittin-activated cellular signaling pathways in rat lactotroph-enriched cell cultures.
Mau SE; Vilhardt H
J Neurochem; 1997 Aug; 69(2):762-72. PubMed ID: 9231737
[TBL] [Abstract][Full Text] [Related]
27. Importance of arachidonic acid metabolites in regulating ATP-induced calcium fluxes in thyroid FRTL-5 cells.
Törnquist K; Ekokoski E; Forss L; Matsson M
Cell Calcium; 1994 Feb; 15(2):153-61. PubMed ID: 8149415
[TBL] [Abstract][Full Text] [Related]
28. Measurement of TSAb directly in serum using FRTL-5 cells.
Vitti P; Chiovato L; Lopez G; Lombardi A; Santini F; Mammoli C; Bassi P; Gryczynska M; Schipani E; Tosti-Balducci M
J Endocrinol Invest; 1988 Apr; 11(4):313-7. PubMed ID: 2900851
[TBL] [Abstract][Full Text] [Related]
29. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
[TBL] [Abstract][Full Text] [Related]
30. The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells.
Kifor O; Diaz R; Butters R; Brown EM
J Bone Miner Res; 1997 May; 12(5):715-25. PubMed ID: 9144337
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'-monophosphate, but by Ca2+ signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative.
Kimura T; Okajima F; Sho K; Kobayashi I; Kondo Y
Endocrinology; 1995 Jan; 136(1):116-23. PubMed ID: 7828520
[TBL] [Abstract][Full Text] [Related]
32. An adenosine derivative cooperates with TSH and Graves' IgG to induce Ca2+ mobilization in single human thyroid cells.
Yanagita Y; Okajima F; Sho K; Nagamachi Y; Kondo Y
Mol Cell Endocrinol; 1996 Apr; 118(1-2):47-56. PubMed ID: 8735590
[TBL] [Abstract][Full Text] [Related]
33. Thapsigargin-induced calcium entry in FRTL-5 cells: possible dependence on phospholipase A2 activation.
Törnquist K; Ekokoski E; Forss L
J Cell Physiol; 1994 Jul; 160(1):40-6. PubMed ID: 8021298
[TBL] [Abstract][Full Text] [Related]
34. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A
Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
[TBL] [Abstract][Full Text] [Related]
35. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
[TBL] [Abstract][Full Text] [Related]
36. Effect of Graves' IgG on gene transcription in human thyroid cell cultures. Thyroglobulin gene activation.
Kung AW; Collison K; Banga JP; McGregor AM
FEBS Lett; 1988 May; 232(1):12-6. PubMed ID: 2835260
[TBL] [Abstract][Full Text] [Related]
37. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
38. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
39. Thyroglobulin release-stimulating activity in immunoglobulin G from patients with Graves' disease studied by human thyroid cells in vitro.
Fukue Y; Uchimura H; Mitsuhashi T; Okano S; Kanaji Y; Takaku F
J Clin Endocrinol Metab; 1987 Feb; 64(2):261-5. PubMed ID: 2878936
[TBL] [Abstract][Full Text] [Related]
40. [Assay of circulating thyroid stimulator determined by I- efflux].
Kobayashi I; Shoda Y; Kuwabara A; Okajima F; Kondo Y
Rinsho Byori; 1994 Sep; 42(9):938-42. PubMed ID: 7967118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
